Abstract
Purpose
To investigate the effects of preoperative steroid administration, including dosage, on complications after gastrectomy for gastric cancer.
Methods
We reviewed patients who underwent gastrectomy for gastric and esophagogastric junctional adenocarcinoma between 2013 and 2019 at the Department of Gastrointestinal Surgery, The University of Tokyo.
Results
Among the total 764 patients eligible for inclusion in the study, 17 were on steroid medication preoperatively (SD group) and 747 were not (ND group). The hemoglobin, serum albumin levels, and respiratory functions were significantly lower in the SD group than in the ND group. The incidence of postoperative complications classified as Clavien–Dindo (C–D) ≥ 2 was significantly greater in the SD group than in the ND group (64.7% vs. 25.6%, p < 0.001). Intra-abdominal infection (35.2% vs. 9.6%, p < 0.001) and anastomotic leakage (11.8% vs. 2.1%, p < 0.001) occurred more frequently in the SD group than in the ND group. On multiple logistic regression analysis for C-D ≥ 3 postoperative complications, the odds ratio for oral steroid use ≥ 5 mg per day as prednisolone had the highest value, of 13.0 (95% confidence interval 2.46–76.2, p < 0.01).
Conclusion
Preoperative oral steroid use was identified as an independent risk factor for postoperative complications after gastrectomy for gastric cancer. Furthermore, the complication rate appears to increase as the oral steroid dosage is increased.
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71(3):209–49.
Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–90.
Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908–14.
Shimada H, Fukagawa T, Haga Y, Oba K. Does postoperative morbidity worsen the oncological outcome after radical surgery for gastrointestinal cancers? A systematic review of the literature. Ann Gastroenterol Surg. 2017;1(1):11–23.
Tokunaga M, Kurokawa Y, Machida R, Sato Y, Takiguchi S, Doki Y, et al. Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial. Gastric Cancer. 2021;24(1):214–23.
Ismael H, Horst M, Farooq M, Jordon J, Patton JH, Rubinfeld IS. Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg. 2011;201(3):305–8.
Eriksen TF, Lassen CB, Gögenur I. Treatment with corticosteroids and the risk of anastomotic leakage following lower gastrointestinal surgery: a literature survey. Colorectal Dis. 2014;16(5):O154–60.
Miki C, Ohmori Y, Yoshiyama S, Toiyama Y, Araki T, Uchida K, et al. Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients. World J Surg. 2007;31(3):522–9.
Nguyen GC, Elnahas A, Jackson TD. The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohns Colitis. 2014;8(12):1661–7.
Subramanian V, Saxena S, Kang JY, Pollok RC. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol. 2008;103(9):2373–81.
Andalib A, Aminian A, Khorgami Z, Jamal MH, Augustin T, Schauer PR, et al. Early postoperative outcomes of primary bariatric surgery in patients on chronic steroid or immunosuppressive therapy. Obes Surg. 2016;26(7):1479–86.
Hefler J, Dang J, Modasi A, Switzer N, Birch DW, Karmali S. Effects of chronic corticosteroid and immunosuppressant use in patients undergoing bariatric surgery. Obes Surg. 2019;29(10):3309–15.
Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25(11):1566–91.
Fujiya K, Kumamaru H, Fujiwara Y, Miyata H, Tsuburaya A, Kodera Y, et al. Preoperative risk factors for postoperative intra-abdominal infectious complication after gastrectomy for gastric cancer using a Japanese web-based nationwide database. Gastric Cancer. 2021;24(1):205–13.
Kikuchi H, Miyata H, Konno H, Kamiya K, Tomotaki A, Gotoh M, et al. Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry. Gastric Cancer. 2017;20(6):987–97.
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Hoboken: Wiley; 2017.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
Fagenson AM, Mazzei M, Edwards MA. Does steroid use in transplant patients undergoing bariatric surgery independently impact outcomes? J Surg Res. 2020;254:294–9.
Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci. 1998;94(6):557–72.
Brauchle M, Fässler R, Werner S. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Investig Dermatol. 1995;105(4):579–84.
Kumagai K, Hiki N, Nunobe S, Jiang X, Kubota T, Aikou S, et al. Potentially fatal complications for elderly patients after laparoscopy-assisted distal gastrectomy. Gastric Cancer. 2014;17(3):548–55.
Lee KG, Lee HJ, Yang JY, Oh SY, Bard S, Suh YS, et al. Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien-Dindo system. J Gastrointest Surg. 2014;18(7):1269–77.
Li ZY, Zhao YL, Qian F, Tang B, Chen J, Zhang F, et al. Incidence and risk factors of postoperative complications after robotic gastrectomy for gastric cancer: an analysis of 817 cases based on 10-year experience in a large-scale center. Surg Endosc. 2021;35(12):7034–41.
Kienle P. Impact of modern drug therapy on surgery: Crohn’s disease. Visc Med. 2018;34(6):422–5.
Baca B, Ozben V, Boler DE, Onur E, Hamzaoglu I, Karahasanoglu T, et al. Effect of corticosteroid dose and duration of administration on colonic anastomosis. Inflamm Bowel Dis. 2010;16(12):2162–7.
Sugerman HJ, Sugerman EL, Meador JG, Newsome HH Jr, Kellum JM Jr, DeMaria EJ. Ileal pouch anal anastomosis without ileal diversion. Ann Surg. 2000;232(4):530–41.
Uchino M, Ikeuchi H, Tsuchida T, Nakajima K, Tomita N, Takesue Y. Surgical site infection following surgery for inflammatory bowel disease in patients with clean-contaminated wounds. World J Surg. 2009;33(5):1042–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We declare no conflicts of interest for this article.
Ethical approval
The protocol for this research project was approved by the Ethics Committee of the University of Tokyo and it conforms to the provisions of the Declaration of Helsinki (Approval No. 3962). Informed consent was obtained from the subjects.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ri, M., Narita, T., Urabe, M. et al. Effects of the preoperative use and dosage of steroids on postoperative complications of gastric cancer surgery. Surg Today 53, 1173–1180 (2023). https://doi.org/10.1007/s00595-023-02698-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-023-02698-6